TopPodcast.com
Menu
  • Home
  • Top Charts
  • Top Networks
  • Top Apps
  • Top Independents
  • Top Podfluencers
  • Top Picks
    • Top Business Podcasts
    • Top True Crime Podcasts
    • Top Finance Podcasts
    • Top Comedy Podcasts
    • Top Music Podcasts
    • Top Womens Podcasts
    • Top Kids Podcasts
    • Top Sports Podcasts
    • Top News Podcasts
    • Top Tech Podcasts
    • Top Crypto Podcasts
    • Top Entrepreneurial Podcasts
    • Top Fantasy Sports Podcasts
    • Top Political Podcasts
    • Top Science Podcasts
    • Top Self Help Podcasts
    • Top Sports Betting Podcasts
    • Top Stocks Podcasts
  • Podcast News
  • About Us
  • Podcast Advertising
  • Contact
Not in our directory?
Add Show Here
Podcast Equipment
Center

toppodcastlogoOur TOPPODCAST Picks

  • Comedy
  • Crypto
  • Sports
  • News
  • Politics
  • True Crime
  • Business
  • Finance

Follow Us

toppodcastlogoStay Connected

    View Top 200 Chart
    Back to Rankings Page
    Life Sciences

    Science Will Win

    Science Will Win is a podcast that takes listeners under the microscope of some of the most promising medical innovations, exploring therapies that have the potential to shape the future of healthcare and offer new hope to patients around the world. Through conversations with a diverse line-up of guests, including scientists and experts, patient advocates, and, most importantly, patients themselves, each miniseries will focus on a unique healthcare challenge, diving into the fascinating science, policy challenges, and potential to transform patients’ lives for the better.

    This podcast is powered by Pfizer.

    Advertise

    Copyright: © 2021-2023 Pfizer Inc

    • Apple Podcasts
    • Google Play
    • Spotify
    Latest Episodes:
    Live from SXSW - Moonshot Culture: Innovating to Outdo Yesterday Apr 18, 2024

    Throughout history, humans have coalesced around moonshot culture to achieve audacious goals—from eradicating smallpox, to sequencing the human genome, to landing a spacecraft on Mars. These feats of human ingenuity didn’t happen in a vacuum, they were born from intentional innovation, a “coalition of the willing,” and a vision to outdo yesterday. This fireside chat with Drew Panayiotou, Former CMO of Pfizer and Devon Still, ex-NFL player and founder of Still Strong Foundation, explores innovations in cancer, their personal experiences with family members needing healthcare treatment, and what it will take to achieve Pfizer's next big moonshot to outdo cancer and achieve its vision, a world where people with cancer live better and longer lives.

    This episode was recorded live in Austin, TX on Monday March 11 as part of Pfizer’s takeover of the South by Southwest podcasting lounge.

    The Let's Outdo Cancer Campaign aims to focus on advances in fighting against cancer. To learn more, visit letsoutdocancer.com.

    Live from SXSW - Scientific Storytelling: The Audio Advantage Apr 18, 2024

    Podcasting has exploded in the last 5 years, with every celebrity, brand, and influencer investing in audio. It’s estimated that 144MM people in the U.S. listen to a podcast monthly. With scale and an ability to build audience connections, podcasts have become effective at communicating complex information in a digestible way–making them perfect for sharing science-based stories. Many have heard the term "gene therapy," but how many know what it means? How do you explain the science behind artificial intelligence or designing the Mars Rover? Audio allows us to do this, while enhancing the impact of science communications. Join the Pfizer Podcast team, NASA, UT Austin, and Wonder Media Network as they share their audio expertise and accessible approach to scientific storytelling.

    Featured experts:

    • Shira Atkins, CRO & Co-Founder, Wonder Media Network
    • Ellen Gerstein, Head Of Digital Communications, Pfizer Inc.
    • Katie Konans, Audio Storytelling Lead, NASA
    • Kristen Wynn, Program Manager, The University of Texas at Austin, Dell Medical School, Livestrong Cancer Institutes

    This episode was recorded live in Austin, TX on Monday March 11 as part of Pfizer’s takeover of the South by Southwest podcasting lounge.

    Live from SXSW - The Future of Cancer Apr 18, 2024

    In a live taping of the Science Will Win podcast, Host and Artificial Intelligence Expert Jeremiah Owyang speaks to cutting-edge healthcare leaders about the impact that AI is having on the future of cancer. Thirty years ago, the thought of a world without cancer was nothing more than a dream. Similarly, AI was considered a technology that had yet to become reality. Today, we are reimagining a future where the AI revolution will help change the trajectory of cancer as we know it.

    Featured experts:

    • Edward Cox, Head & General Manager Of Digital Health & Medicines, Pfizer
    • Julie Gerberding, CEO and President, Foundation for the National Institutes of Health
    • Maimah Karmo, Founder & CEO, Tigerlily Foundation

    This episode was recorded live in Austin, TX on Monday March 11 as part of Pfizer’s takeover of the South by Southwest podcasting lounge.

    Part 4 – Using AI to Get One Step Ahead of Antibiotic Resistance Dec 05, 2023

    Is it possible to live in a world without antibiotic resistant bacteria? For the final episode of this season, we’re looking ahead to the future and getting a glimpse of a potential world in which we stay one step ahead of AMR, and what is helping us get there. Host Jeremiah Owyang and expert guests will talk about the education, surveillance, and policy efforts needed for success in the fight against antibiotic resistant bacteria. And we’ll explore how artificial intelligence can empower us in those efforts — and enable more effective, accessible, and equitable healthcare.

    Featured Guests:

    • Dame Sally Davies, UK Special Envoy for Antimicrobial Resistance
    • Daniel Gallego, President of the European Kidney Patient Federation
    • Ranjit Kumble, Vice President of Enterprise Data Science and Advanced Analytics, Pfizer
    • Subha Madhavan, Vice President & Head of AI/ML, Quantitative & Digital Sciences, Global Biometrics & Data Management
    • Jay Purdy, Vice President and Therapeutic Area Lead, Global Medical Affairs, Pfizer Antibacterial and Antifungal Programs

    Season 3 of Science Will Win is created by Pfizer and hosted by Jeremiah Owyang, entrepreneur, investor, and tech industry analyst. It’s produced by Wonder Media Network.

    Part 3 – AI in the Lab: Accelerating Antibiotic Discovery Nov 28, 2023

    Artificial intelligence has the power to transform the way researchers study bacteria and develop new treatments – and we’re already seeing the benefits in healthcare. In part three, host Jeremiah Owyang and expert guests shed light on how AI expedites and enhances analyses, revolutionizing the search for new antibiotics. The benefits of AI extend to analyzing bacterial DNA, uncovering vulnerabilities, and potentially predicting bacterial evolution. This innovative technology aids scientists in pinpointing the most promising antibiotic candidates from a sea of possibilities and helps to streamline drug development.

    Featured Guests:

    • Adrian Egli, Director, Institute of Medical Microbiology, University of Zurich
    • Lei Zhang, Executive Director of Medicinal Chemistry, Pfizer Medicine Design
    • Marinka Zitnik, Assistant Professor, Department of Biomedical Informatics, Harvard Medical School; Co-founder, Therapeutics Data Commons

    Season 3 of Science Will Win is created by Pfizer and hosted by Jeremiah Owyang, entrepreneur, investor, and tech industry analyst. It’s produced by Wonder Media Network.

    Part 2 – The Power of Data and Artificial Intelligence Nov 21, 2023

    Artificial intelligence could be an essential tool in the fight against antibiotic resistant bacteria – and data is a key part of developing that tool. In part two of this four-part series, expert guests break down the mechanics behind artificial intelligence and machine learning. As host Jeremiah Owyang traces the evolution of these tools in healthcare, he highlights the crucial role of data for understanding the problem of antibiotic resistance.

    Featured Guests:

    • Adrian Egli, Director, Institute of Medical Microbiology, University of Zurich
    • Ranjit Kumble, Vice President of Enterprise Data Science and Advanced Analytics, Pfizer
    • Marinka Zitnik, Assistant Professor, Department of Biomedical Informatics, Harvard Medical School; Co-founder, Therapeutics Data Commons

    Season 3 of Science Will Win is created by Pfizer and hosted by Jeremiah Owyang, entrepreneur, investor, and tech industry analyst. It’s produced by Wonder Media Network.

    Part 1 – The Battle Against Antibiotic Resistance Nov 15, 2023

    Medicine’s struggle with antibiotic resistant bacteria is reaching a crisis point. In part one of this four-part series, host Jeremiah Owyang and expert guests delve into the world of antibiotics, exploring their history, the rise of antibiotic resistance, and the story of a patient whose life was forever changed by antibiotic-resistant bacteria. They break down the critical issues at stake and discuss the multifaceted solutions needed to combat this pressing crisis – including artificial intelligence.

    Featured Guests:

    • Adrian Egli, Director, Institute of Medical Microbiology, University of Zurich
    • Jay Purdy, Vice President and Therapeutic Area Lead, Global Medical Affairs, Pfizer Antibacterial and Antifungal Programs
    • Mary Lynne Van Poelgeest-Pomfret, President, World Federation of Incontinence and Pelvic Problems

    Season 3 of Science Will Win is created by Pfizer and hosted by Jeremiah Owyang, entrepreneur, investor, and tech industry analyst. It’s produced by Wonder Media Network.

    Coming Soon – Science Will Win, Season 3 Nov 07, 2023

    Since antibiotics were first discovered, bacteria have been evolving to outsmart them. But today, the latest science is rising up to meet the challenge. This season of Science Will Win is exploring how artificial intelligence (AI) can help the scientific community overcome one of the greatest challenges facing humanity: antimicrobial resistance. This season, we’ll hear from researchers, doctors, patients, patient advocates, computer scientists, and AI experts. All of them are on the cutting edge of the fight against antimicrobial resistance. Tune in to this new, four-part series, coming soon!

    Season 3 of Science Will Win is created by Pfizer and hosted by Jeremiah Owyang, entrepreneur, investor, and tech industry analyst. It’s produced by Wonder Media Network.

    Part 2: Clinical Trials: Bringing Research to Life Oct 27, 2022

    In part two of this series, Adam Rutherford and guests break down the next step in how potential breast cancer treatments move forward from the lab. What role do clinical trials play in the development of potential treatments? How are clinical trials developed? How can patients access clinical trials? And how are researchers and advocacy groups working to break down barriers in access to clinical trials?

    Featured Guests:

    • Laurie, Breast Cancer Clinical Trial Participant
    • Dr. Edith Mitchell, Medical Oncologist, Thomas Jefferson University
    • Julia Perkins Smith, Global Clinical Lead, Pfizer
    • Jamil Rivers, CEO, Chrysalis Initiative

    Additional Resources:

    • pfizerclinicaltrials.com/oncology
    • pfizerclinicaltrials.com
    • pfizerestudiosclinicos.com
    Part 1: Breast Cancer: The Science, The Challenges, The Solutions Oct 27, 2022

    Oncologists have more innovative methods for treating breast cancer than ever before. In part one of this two-part series, Adam Rutherford and guests explore the hurdles and successes researchers face as they work to develop new, targeted therapies for breast cancer.

    Featured Guests:

    • Martha Carlson, Breast Cancer Advocate & Writer
    • Dr. Edith Mitchell, Medical Oncologist, Thomas Jefferson University
    • Jeff Settleman, Chief Scientific Officer, Pfizer Oncology
    Coming Soon – Science Will Win, Season 2 Oct 13, 2022

    Host Adam Rutherford returns to explore breakthroughs in oncology, the study and treatment of cancer, and more specifically breast cancer. We’ll hear from the scientists tasked with developing new treatments, oncologists who lead clinical trials and treat patients, and the patients and patient advocates themselves. It’s a groundbreaking time for cancer research, with as many promising possibilities as there are challenges to overcome. Tune in to this new, two-part series, launching October 27, 2022!

    BONUS – Into the Pfizer Lab: Making a Gene Therapy Dec 10, 2021

    In this special bonus episode, Adam Rutherford explores a different aspect of gene therapy - how do you actually make one? Expert guests discuss the highly complex task of scaling-up manufacturing from the small amounts needed for research, to creating batches big enough for clinical and commercial scale. And once that hurdle has been cleared, how do they address the additional challenge of storing and transporting the medicine at ultra-low temperatures?

    Featuring guests:
    Bert Bruce, Regional President, North America, Rare Disease, Pfizer
    Bob Smith, Senior Vice President, Global Gene Therapy Business, Rare Disease, Pfizer
    Sonal Bhatia, Chief Medical Officer, Rare Disease, Pfizer

    What’s Next For Gene Therapy? Oct 29, 2021

    Gene therapy is at a pivotal moment. For eligible rare disease patients, the potential impact could be huge. So how can we support that potential to fruition and what will it mean if we do? In our season finale, host Adam Rutherford and guests take a peek into what a world with successful gene therapies could look like for patients, healthcare and society.

    Featuring guests:
    Durhane Wong-Rieger, President & CEO at Canadian Organization for Rare Disorders
    Erik Paulsen, Chair, Institute for Gene Therapies
    Karolina Hanslik, Former Senior Project Manager, EURORDIS
    Nikhil Gadre, Senior Director, Global Commercial, Hemophilia Gene Therapy, Pfizer
    Paige Bischoff, Senior Vice President, Global Public Affairs, Alliance for Regenerative Medicine
    Paolo Morgese, EU Director, Market Access, Alliance for Regenerative Medicine
    Reda Guiha, IDM Regional President, Rare Disease, Pfizer
    Simone Boselli, Director, Public Affairs, EURORDIS
    Tomislav Sokol, Member of European Parliament

    The Policy Puzzle Oct 22, 2021

    As with any new breakthrough medicine, entering the healthcare system comes with a host of obstacles and potential barriers. In this episode, Adam Rutherford and guests break down the big changes needed within the global healthcare ecosystem to ensure that, once approved, the therapies we’re researching now, like gene therapy, reach the patients who need them.

    Featuring guests:
    Bert Bruce, Regional President, North America, Rare Disease, Pfizer
    Brenda Cooperstone, Senior Vice President, Chief Development Officer, Rare Disease, Pfizer
    Durhane Wong-Rieger, President & CEO at Canadian Organization for Rare Disorders
    Emily Crossley, Chief Executive Officer, Duchenne UK
    Erik Paulsen, Chair, Institute for Gene Therapies
    Karolina Hanslik, Senior Project Manager, EURORDIS
    Katherine Beaverson, Senior Director and Patient Advocacy Lead, Rare Disease Research Unit, Pfizer
    Nikhil Gadre, Senior Director, Global Commercial, Hemophilia Gene Therapy, Pfizer
    Suneet Varma, Global President, Rare Disease, Pfizer
    Tomislav Sokol, Member of European Parliament

    Clinical Trials: Courage and Perseverance Oct 15, 2021

    Gene therapy has come a long way to get where it is today but there is still much to learn and investigate. Host Adam Rutherford speaks to a line-up of experts about the vital role of clinical trials and the unique challenges facing gene therapy and rare disease patients.
    Featuring guests:
    Brenda Cooperstone, Senior Vice President, Chief Development Officer, Rare Disease, Pfizer
    Emily Crossley, Chief Executive Officer, Duchenne UK
    Erik Paulsen, Chair, Institute for Gene Therapies
    Professor John Rasko, Clinical Haematologist & Trial Investigator, University of Sydney
    Simone Boselli, Director, Public Affairs, EURORDIS
    Suneet Varma, Global President, Rare Disease, Pfizer

    Gene Therapy – Behind the Science Oct 08, 2021

    Gene therapy is a revolutionary field of science that has the potential to transform lives. It presents this big question; What if we could treat a disease at its root cause, rather than just the symptoms? On the first episode of Science Will Win, host Adam Rutherford takes us through the history, science, and significance of gene therapy.

    Featuring guests:

    Dirk Vander Mijnsbrugge, Vice President, Medical Affairs, Rare Diseases, Pfizer
    Durhane Wong-Rieger, President & CEO at Canadian Organization for Rare Disorders
    Laurence Woollard, Director, On The Pulse Consultancy
    Sonal Bhatia, Chief Medical Officer, Rare Disease, Pfizer

    New Series — Science Will Win Aug 31, 2021

    Science Will Win explores the fascinating science, policy, and humanity which is shaping the future of healthcare and transforming patients’ lives for the better.

    Hosted by Adam Rutherford, geneticist and Honorary Fellow at University College London, our first miniseries takes listeners on a journey behind the science of gene therapy; the next generation of medicines bringing new possibilities for patients living with rare genetic diseases.

    At a time when innovative science is achieving the seemingly impossible, we’ll look at gene therapy from every angle, speaking to scientists and experts on the forefront of medical research, as well as the patients and families who are holding new hope in the life-changing potential of gene therapy.

      Related Podcasts

      Unexplainable

      1

      Unexplainable Life Sciences
      Neuroscience: Amateur Hour

      2

      Neuroscience: Amateur Hour Life Sciences
      COMPLEXITY

      3

      COMPLEXITY Life Sciences
      Speaking of Psychology

      4

      Speaking of Psychology Government & Organizations
      Personal Genomics – A Podcast from the Center for Cancer Genomics

      5

      Personal Genomics – A Podcast from the Center for Cancer Genomics Life Sciences
      Lionhearted Dentists with Dr. Steve Rasner

      6

      Lionhearted Dentists with Dr. Steve Rasner Health & Fitness
      footer-logo

      Contact Us

      Toll Free: 844-670-7747

      Links

      • Home
      • Top Charts
      • Networks
      • Apps
      • Independents Podcasts
      • Podcast Advertising
      • Podcast News
      • Contact Us
      • About Us
      • Analytics & Insights

      Stay Connected

        Privacy, Terms of Use & Our Code of Ethics Protecting Content Creators Copyrights